Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0755
For the purpose of parts 4615.0750 to 4615.0760, the following terms have the meanings given them.
"Department" means the Minnesota Department of Health.
"Follow-up services" means assisting the patient in accessing appropriate treatment and other services.
"Patient" means the person who has been diagnosed with hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and/or congenital adrenal hyperplasia or the person's parents or legal guardian.
"Physician" means the medical doctor licensed under Minnesota Statutes, chapter 147, who is supervising the ongoing treatment of the patient. The patient may identify more than one such physician.
"Registry" means a permanent record maintained by the department on each patient diagnosed by a physician and reported to the department as having hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and/or congenital adrenal hyperplasia.
"Treatment control test" means a laboratory test to monitor medical treatment in diagnosed patients to assist in the medical management of the patient's metabolic disease.
"Treatment control test specimen" means a specimen of blood or other body fluid collected from a patient.
"Treatment control test specimen kit" means a kit containing suitable containers and other materials provided by the department and used to collect and transport a treatment control test specimen.
Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0755
Statutory Authority: MS s 144.125; 144.128